Clinical Sciences articles for National Institutes of Health (NIH), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 253

Article ‘Count’ for Clinical Sciences.

Journal Count Share
1 0.06
Longitudinal micronutrient exposure reveals country-specific associations with risk of celiac disease in genetically susceptible children: the prospective TEDDY cohort 0.06
3 1.19
Measuring disease likelihood in genomic ascertainment 0.72
Single-cell analysis of human fibrous dysplasia bone reveals a fibrotic transcriptome and GNAS variants in endothelial, perivascular, and stromal cells 0.42
Exploring depression treatment response by using polygenic risk scoring across diverse populations 0.05
1 0.08
Outcomes by Frailty and Mobility In Older Patients Undergoing Major Urogynecologic Surgery: A Planned Supplementary Study of the ASPIRe Trial 0.08
1 0.50
Selective Depletion of Gut Gram-Negative Bacteria Attenuates Alcohol-Binge-Induced Cardiovascular Dysfunction by Lowering Cardiac Anandamide Levels 0.50
1 0.03
Effects of an early restrictive versus liberal fluid strategy on long-term patient-centered outcomes in sepsis-induced hypotension (SHAMROC): an open-label, randomized controlled trial 0.03
4 0.32
Association between Human Leukocyte Antigen Alleles and Neuropathological Outcomes in Lewy Body Disease 0.07
Midlife Steroid‐Binding Globulin Levels and iIn Vivo/i Neuroimaging Measures of Tau in Older Men and Women 0.04
Biallelic Variants in the scpiDARS2/i/scp Gene as a Novel Cause of Axonal Charcot–Marie–Tooth Disease 0.04
Proteomics and the Risk of Incident Embolic and Thrombotic Stroke 0.17
1 0.07
Upfront Colectomy vs. Initial Appendectomy followed by Completion Colectomy for Appendiceal Cancer: A Comparison of Outcomes. 0.07
7 1.49
Myeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers 0.31
A phase 2, randomised, placebo-controlled study of guselkumab in adults with new-onset or relapsing giant cell arteritis 0.07
Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approach 0.08
A de novo dominant-negative PSMB8 mutation causes severe CANDLE/PRAAS due to arrested proteasome biogenesis 0.22
Myositis-specific autoantibodies recognising Mi2 also target the AIRE protein at a shared PHD zinc finger 0.71
Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtype 0.07
A glossary of signs and symptoms of giant cell arteritis 0.03
6 2.54
18F‐Fluorodeoxyglucose Positron Emission Tomography Imaging Assessment within a Randomized Controlled Trial in Giant Cell Arteritis 0.25
ANK1 and EPB41 Variants and the Risk of Steroid-Induced Osteonecrosis 0.14
Improved Detection of Myositis‐Specific Autoantibodies Using Luciferase Immunoprecipitation Systems Assay: Comparison With Line Blot and Conventional Immunoprecipitation 0.73
Dysregulation of U12-Type Splicing in Lupus Neutrophils 1.00
Multi‐Omic Profiling Reveals Immune Cell Priming Signature Linked to Lupus Prognosis 0.29
Deficiency of AP1M2 causes a new autoinflammatory disease with colitis 0.13
4 1.07
Systematic discovery of pro- and anti-HIV host factors in primary human CD4+ T cells 0.08
Kiwa is a membrane-embedded defense supercomplex activated at phage attachment sites 0.13
Structural insights into brain thyroid hormone transport via MCT8 and OATP1C1 0.29
Trichophyton concentricum fungal infections and skin microbiomes of Indigenous Peninsular Malaysians 0.57
3 1.43
Metabolic cross-feeding of a dietary antioxidant enhances anaerobic energy metabolism by human gut bacteria 0.38
Restoration of the human skin microbiome following immune recovery after hematopoietic stem cell transplantation 1.00
Microbial contribution to metabolic niche formation varies across the respiratory tract 0.05
2 0.37
Associations between Prior Lung Diseases and Risk of Lung Cancer in Populations With No Smoking History: A Systematic Review and Meta-Analysis 0.17
Poor olfaction is associated with lower pulmonary function in older adults 0.20
11 0.94
Impact of Procalcitonin Testing on Antibiotic Use in Patients Hospitalized With Community-Acquired Pneumonia: A Multi-Hospital Cohort Study 0.10
A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391) 0.13
Patterns of HIV-1 Viral Load Suppression and Drug Resistance During the Dolutegravir Transition: A Population-based Longitudinal Study 0.14
Regional variations of rates and determinants of drug resistance mutations in people failing first-line therapy for HIV-1: a substudy from the D2EFT phase 3b/4 clinical trial 0.02
The Bounce-Back Effect: What Happens After Cessation of Low-Dose Semaglutide in People with HIV 0.11
Long-term clinical, immunologic, and viral reservoir outcomes in children treated with VRC01LS and 10-1074 monoclonal antibodies in the Tatelo Study 0.11
Randomized Pragmatic Trial of the Comparative Effectiveness of Chicken Egg-Based Inactivated, Mammalian Cell Culture-Based Inactivated, and Recombinant Protein Quadrivalent Seasonal Influenza Vaccines in United States Military Health System Beneficiaries 0.02
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative Pathogens 0.06
Phase 2 Trial of Long-Acting Cabotegravir and VRC07-523LS for Viral Suppression in Adults with HIV-1: ACTG A5357 0.14
A randomised trial to compare dolutegravir plus boosted darunavir versus recommended standard of care antiretroviral regimens in people with HIV-1, whose first-line non-nucleoside reverse transcriptase inhibitor therapy has failed: Final 96-week results of the D2EFT study 0.03
Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022 0.09
4 1.47
Distinct contributions of anterior and posterior orbitofrontal cortex to outcome-guided behavior 0.43
Excitatory drive to the globus pallidus external segment facilitates action initiation in non-human primates 0.75
Disentangling prediction error and value in a formal test of dopamine’s role in reinforcement learning 0.04
Endogenous and exogenous attentional interplay through mixed prefrontal cortex resources 0.25
1 0.03
Concerted changes in Epithelium and Stroma: a multi-scale, multi-omics analysis of progression from Barrett’s Esophagus to adenocarcinoma 0.03
1 0.14
Interlaboratory Evaluation of Multiplex Autoantibody Assay Performance in the Islet Autoantibody Standardization Program 2024 Workshop. 0.14
2 0.31
Exposure to organophosphate esters and trajectories of gestational weight gain: A large prospective cohort study 0.19
Fetal exposure to bisphenols and phthalates and risk of respiratory conditions in infancy. The Generation R Next Study 0.13
1 0.05
Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance 0.05
3 0.19
MAIT cell enrichment in Lynch syndrome is associated with immune surveillance and colorectal cancer risk 0.06
Novel insights into autoimmune gastritis: clinical profile and gastric neoplastic risk from an international multicentre study 0.02
Zinc-dependent RNA-binding protein controls hepatocyte senescence and recovery from alcohol-related liver failure 0.11
4 2.12
Genetically diverse influenza antibodies highlight the role of IG germline gene variation and inform population-comprehensive vaccine strategies 0.11
HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized mice 0.20
Commensal-derived trehalose monocorynomycolate triggers γδ T cell-driven protective ocular barrier immunity 0.81
Naturalized immune responses are stable over years in a colony of laboratory mice with wild-derived microbiota 1.00
2 0.20
Acute-phase reactants as predictors of chronic kidney disease incidence in Africans: the population-based prospective RODAM cohort study 0.03
Age and gender profiles of HIV infection burden and viraemia: novel metrics for HIV epidemic control in African populations with high antiretroviral therapy coverage 0.18
1 0.06
The Physiology Of the WEight Reduced State (POWERS) study: strategies for the analysis of biological specimens 0.06
3 0.14
Extended-Release vs Sublingual Buprenorphine in Pregnancy Through 12 Months Post Partum 0.05
Collaborative Care for Opioid Use Disorder and Mental Illness 0.05
Clinical Decision Support System for Primary Care of Opioid Use Disorder 0.04
2 0.15
Processing Speed Impairment in Schizophrenia 0.08
Collaborative Care for Opioid Use Disorder in Primary Care 0.07
1 0.04
Global Scaling of a Surgical Infection Prevention Program to 5 Low-Resource Countries 0.04
6 0.23
Symptom-Based Dosing for Neonatal Opioid Withdrawal 0.03
National Estimates of Pediatric Sepsis in US Hospitals Using Clinical Data 0.06
Emergency Department–Initiated Buprenorphine for Opioid Use Disorder 0.03
Minor Papillotomy for Treatment of Idiopathic Acute Pancreatitis With Pancreas Divisum 0.06
Discordance in Creatinine- and Cystatin C–Based eGFR and Clinical Outcomes 0.03
Dalbavancin for Treatment of Staphylococcus aureus Bacteremia 0.02
3 2.35
Cell type-specific expression and subcellular localization of the human insulin upstream open reading frame (INSU) protein in pancreatic β-cells 0.91
The Multiple Sclerosis Drug Fingolimod Induces Pore-Like Membrane Defects, Contributing to Its Antimicrobial Activity 0.44
Evidence against efficient spontaneous disassembly of prions into small oligomers 1.00
9 5.60
Comparing surrogate indexes for insulin resistance as predictors of type 2 diabetes 1.00
Genotype-phenotype heterogeneity among patients with lipodystrophy harboring rare POLD1 variants 0.33
<atl>Expanding the clinical tumor phenotype of the iEPAS1/i -asssociated tumor syndrome</atl> 0.21
Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study 0.93
Clinical and Biochemical Phenotype Across the Genotypic Spectrum of 21-Hydroxylase Deficiency in 457 Individuals 0.92
The Importance of Disease Specific Growth Charts for Children with Congenital Adrenal Hyperplasia 0.25
Association Between Testosterone Replacement Therapy and Prostatic Disorders in Elderly Hypogonadal Men 1.00
Longitudinal Characterization and Sonographic Staging of Testicular Adrenal Rest Tumors 0.93
Impact of Abdominal and Thigh Intermuscular Adipose Tissue on Glucose and Cardiometabolic Risk in Adults With Obesity 0.04
5 1.23
Smac mimetic combined with eCD4-Ig reverses latency without reducing SHIV reservoirs in rhesus macaques 0.04
MEK inhibitor Mirdametinib promotes fracture healing in osteofibrous dysplasia RASopathy 0.11
Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young children 0.02
Distinct neuronal alterations distinguish two subtypes of sporadic Creutzfeldt-Jakob disease with shared dysfunctional pathways 0.90
Boosting SIV-specific CD8+ T cell responses prior to ART interruption extends time to SIVmac239 rebound 0.17
4 1.40
Alternatively activated monocyte-derived myeloid cells promote extracellular pathogen persistence in pulmonary fungal granulomas 0.79
Dynamics of natural and pharmacologic control of an SIV variant with an envelope trafficking defect 0.07
Design and characterization of HIV-1 vaccine candidates to elicit antibodies targeting multiple epitopes 0.20
Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies 0.35
2 0.67
Genetic evidence that FGF21 signaling reduces problematic alcohol use and alcohol‐related liver disease 0.63
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trials 0.04
12 3.87
Pre–Antiretroviral Therapy Vertical HIV-1 Transmission Risk in Uganda Varies by Sex of Child and Maternal Viral Subtype 0.37
Safety, tolerability, and pharmacokinetics of 6-diazo-5-oxo-L-norleucine (DON) in Malawian adults with and without malaria: a Phase I dose-escalation clinical trial 0.21
Association of Plasma Biomarkers of Immunothrombosis With Death in Patients With Coronavirus Disease 2019 on Extracorporeal Membrane Oxygenation 0.34
Immune-Based Cytokine Signatures of Prolonged Pandemic-Associated Chilblains 0.71
Frailty in People with HIV is Linked to Inflammation, Bone Health, and T cell Exhaustion 0.09
Genomic Evolution of Influenza A Virus During the 2024-2025 Season, the Johns Hopkins Health System: Antigenic Drift Reduces Serum Neutralization 0.07
Inflammasome activation and oxidative stress in SARS-CoV-2 infection and symptomatic rebound 0.81
Human Immunodeficiency Virus–Associated Proteomic Signature of Myocardial Fibrosis and Incident Heart Failure 0.25
Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty Quantification 0.41
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083 0.05
Priming or Boosting iPlasmodium falciparum/i Transmission-Blocking Responses With Recombinant Vaccines or Gametocyte Extract 0.23
Deletion of Galectin-3 Renders Mice Less Susceptible to iCandida auris/i Skin Infection by Enhancing Antifungal Activity of Neutrophils 0.33
4 3.32
A distinct circuit for biasing visual perceptual decisions and modulating superior colliculus activity through the mouse posterior striatum 1.00
Neuronal features of visual attention in the mouse superior colliculus depend on learned behavioral relevance 1.00
Domain-general neural effects of associative learning and expectations on pain and hedonic taste perception 0.32
The orbitofrontal cortex underlies consolidation of Pavlovian anticipatory arousal responses in macaque monkeys 1.00
1 0.10
Structural Brain Correlates of Childhood Inhibited Temperament: An ENIGMA-Anxiety Mega-Analysis 0.10
1 0.02
Clinical Practice Guidelines for the Management of Basal Cell Carcinoma in Gorlin Syndrome 0.02
2 0.23
Deciphering Ibogaine’s Matrix Pharmacology: Multiple Transporter Modulation at Serotonin Synapses 0.09
Chemical Synthesis of Oligosaccharides Derived from Streptococcus Pneumoniae Serotype 35B and D Provides Molecular Insight in l-Ficolin Binding 0.14
1 0.04
Myocardial Amyloid Burden in Transthyretin Amyloidosis 0.04
3 0.50
Loss of Cyclin G-Associated Kinase Leads to Lysosome Dysfunction and Immune Modulation in Podocytes. 0.09
Pyruvate Dehydrogenase and Cellular Metabolism in Calcineurin Inhibitor-Induced Kidney Fibrosis. 0.29
Higher versus Lower Phosphate Targets for Patients Undergoing In-Center Hemodialysis: A Randomized Controlled Trial. 0.13
2 1.05
Redefining neurocognitive outcomes after radiation for brain metastases: a patient-level meta-analysis of recovery following initial decline 0.11
Lipid biomarkers of habitual alcohol intake and associations with pancreatic cancer risk 0.94
3 0.25
Independent association between acute kidney injury and kidney function trajectory 0.06
Inactivation of Pkd2 in adult mice results in delayed cyst formation and identifies sex as a major modifier of disease severity. 0.14
A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis 0.04
2 0.22
Microhomology-mediated end joining acts directly on replication forks to repair single-ended double-strand breaks 0.12
FMRP drives mRNP targets into translationally silenced complexes 0.10
5 1.38
Grin2a knockout in adolescent dopamine neurons disrupts prediction error signaling and produces a phenotype relevant to schizophrenia 0.10
Polysubstance use disorders among US adults 0.60
Trends and patterns of medical stimulant use by US adults 0.25
Structural brain differences associated with panic disorder: an ENIGMA-Anxiety Working Group mega-analysis of 4924 individuals worldwide 0.03
The 4-alkyl chain length of 2,5-dimethoxyamphetamines differentially affects in vitro serotonin receptor actions versus in vivo psychedelic-like effects 0.40
10 1.58
Sleep chart of biological ageing clocks in middle and late life 0.19
White matter micro- and macrostructure brain charts for the human lifespan 0.06
Dynamic antigen expression and cytotoxic T cell resistance in HIV reservoir clones 0.05
Correlates of HIV-1 control after combination immunotherapy 0.15
Integrator dynamics in the cortico-basal ganglia loop for flexible motor timing 0.20
Rare genetic variants confer a high risk of ADHD and implicate neuronal biology 0.00
The Panoptes system uses decoy cyclic nucleotides to defend against phage 0.11
Cocaine chemogenetics blunts drug-seeking by synthetic physiology 0.77
Multiple oestradiol functions inhibit ferroptosis and acute kidney injury 0.02
Determinants of successful AAV-vectored delivery of HIV-1 bNAbs in early life 0.03
47 14.33
ToxiTaRGET: a multi-omics database for toxicant-responsive molecular targets 0.09
Acute sleep rebound following sleep restriction is associated with reduced mortality risk 0.13
Coupled cross-sectional and longitudinal non-negative matrix factorization reveals dominant brain aging trajectories in 48,949 individuals 0.21
Small RNA genomics of Aedes aegypti mosquitoes discovers infectious viruses that trigger an RNA interference response 0.06
SARS-CoV-2 vaccination and infection elicit cross-neutralizing responses against clade 3 and 4 sarbecoviruses 0.93
HIV-1 uncoating location dictates sites of integration 0.90
Non-canonical IL‑22 receptor signaling remodels the oral mucosal barrier during Candida albicans immunosurveillance 0.07
IgA autoantibodies promote inflammation, Th17 polarization and fibrotic responses in hidradenitis suppurativa 0.50
Multi-omic identification of key transcriptional regulatory programs during endurance exercise training in rats 0.01
CXCR4-tropic HIV-1 infection in an immunocompetent monkey model 0.03
A stabilized tandem antigen chimera that elicits potent malaria transmission-reducing activity 0.10
Using the linear references from the pangenome to discover missing autism variants 0.04
Individual and population-level risk factors for new HIV infections among adults in Eastern and Southern Africa 0.02
Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk 0.04
Methylphenidate reorganizes cortical hierarchy through dopaminergic modulation 0.96
Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations 0.34
Multiplex serology reveals age-specific immunodynamics of respiratory pathogens in the wake of the COVID-19 pandemic 0.11
Enhanced neural plasticity in monkey TE compared to TEO during learning of a feature-ambiguous visual categorization task 0.67
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC 0.15
Contribution of amygdala to dynamic model arbitration under uncertainty 0.33
Cocaine seeking and consumption are oppositely regulated by mesolimbic dopamine in male rats 0.09
Exploring penetrance of clinically relevant variants in over 800,000 humans from the Genome Aggregation Database 0.01
Single-cell mRNA-regulation analysis reveals cell type-specific mechanisms of type 2 diabetes 0.04
Motion impact score for detecting spurious brain-behavior associations 0.03
HIV vaccine candidate ΔV1gp120 formulated in ALFQA adjuvant augments mucosal immunity in female macaques 0.59
High expression of Rex-orf-I and HBZ mRNAs and bronchiectasis in lung of HTLV-1A/C infected macaques 0.77
VTA monosynaptic connections by local glutamate and GABA neurons and their distinct roles in behavior 1.00
Corticonigral projections recruit substantia nigra pars lateralis dopaminergic neurons for auditory threat memories 0.58
Structural basis for HIV-1 capsid adaption to a deficiency in IP6 packaging 0.17
Hyaluronidase-enhanced subcutaneous delivery of bNAbs: a phase 1 randomized controlled clinical trial in HIV-uninfected women 0.60
Neural correlates of human fear conditioning and sources of variability in 2199 individuals 0.01
Anti-restriction functions of injected phage proteins revealed by peeling back layers of bacterial immunity 0.17
A decision-space model explains context-specific decision-making 0.04
AI-driven fusion of multimodal data for Alzheimer’s disease biomarker assessment 0.02
Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations 0.09
Antimicrobial peptide class that forms discrete β-barrel stable pores anchored by transmembrane helices 0.52
Intracellular pathogen effector reprograms host gene expression by inhibiting mRNA decay 1.00
Identification of gut bacteria reductases that biotransform steroid hormones 0.40
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge 0.00
Variants in cause a novel oculo vertebral renal syndrome 0.67
Dual role of circulating and mucosal Vδ1 T cells in the control of and contribution to persistent HIV-1 infection 0.04
An intracranial dissection of human escape circuits 0.11
HIV-1 vif mediates ubiquitination of the proximal protomer in the APOBEC3H dimer to induce degradation 0.41
Prion-induced ferroptosis is facilitated by RAC3 0.32
Confirmation bias through selective readout of information encoded in human parietal cortex 0.07
Molecular basis of the urate transporter URAT1 inhibition by gout drugs 0.18
Antigen persistence and TLR stimulation contribute to induction of a durable HIV-1-specific neutralizing antibody response 0.70
1 0.02
Genome-wide association study of major anxiety disorders in 122,341 European-ancestry cases identifies 58 loci and highlights GABAergic signaling 0.02
1 0.13
The human brain modulates sniffs according to fine-grained perceptual features of odours 0.13
3 0.08
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size 0.02
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy 0.02
Mammary intraepithelial lymphocytes and intestinal inputs shape T cell dynamics in lactogenesis 0.04
7 1.15
Integrated epidemiological and molecular data inform the relationship between precancer and cancer states of esophageal adenocarcinoma 0.01
Deleterious coding variation associated with autism is shared across ancestries 0.00
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial 0.96
Long-term efficacy and safety of the single-dose tetravalent Butantan dengue vaccine 0.03
Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy 0.11
Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study 0.00
Prevention of type 2 diabetes through prediabetes remission without weight loss 0.05
2 0.13
Serotonergic modulation of the BNST–CeA pathway reveals sex differences in fear learning 0.05
Noradrenergic activation of the basolateral amygdala facilitates memory specificity for similar events experienced close in time 0.08
2 0.89
Risk reshapes amygdala representation of choice 0.87
The polypharmacology of psychedelics reveals multiple targets for potential therapeutics 0.03
1 0.50
Comparative whole-genome analyses of articular chondrocytes and skin fibroblasts reveal distinct genome instability landscapes in mesenchymal cell types 0.50
1 0.17
Evaluating the biomedical and behavioral drivers of HIV incidence decline in adolescent girls and young women in Uganda: A mathematical modeling study 0.17
13 6.24
Antiretroviral therapy blocks natural selection on protective and disease-susceptible HLA-B alleles in HIV-1 infection 0.03
Predicting individual incubation of opioid craving by whole-brain functional connectivity 0.81
Fear extinction induces maladaptive generalization via noradrenergic and GABAergic systems 0.04
Lamin B receptor upregulation in metastatic melanoma causes nuclear envelope fragility in confined migration during cancer invasion 0.71
A quorum-sensing molecule from Pseudomonas aeruginosa induces defensive multicellularity in a coinfecting pathogen 1.00
Primate gut microbiota induce evolutionarily salient changes in mouse neurodevelopment 0.10
Maladaptive immunity to the microbiota promotes neuronal hyperinnervation and itch via IL-17A 0.49
Antibiotic-induced microbiota depletion impairs the proregenerative response to a biological scaffold 0.07
Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancer 0.67
Distinct prelimbic cortex ensembles encode response execution and inhibition 1.00
A unified model of transient poration induced by antimicrobial peptides 0.50
Therapeutic CD8+ T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound 0.07
Contribution of glutamatergic projections to neurons in the nonhuman primate substantia nigra pars reticulata for reactive inhibition 0.75
1 0.06
Risk Stratification of Sudden Cardiac Death in Nonischemic Dilated Cardiomyopathy: Arrhythmogenic Substrate Assessment in Cardiac MRI. 0.06
2 0.12
Induction of broadly neutralizing HIV antibodies by a two-step mechanism informs vaccine design 0.02
Molecular glues that facilitate RAS binding to PI3Kα promote glucose uptake without insulin 0.11
8 4.55
Immunity to hemagglutinin and neuraminidase results in additive reductions in airborne transmission of influenza H1N1 virus in ferrets 0.33
Animal-associated jumbo phages as widespread and active modulators of gut microbiome ecology and metabolism 0.13
Restriction of HIV-1 infectivity by interferon and IFITM3 is counteracted by Nef 0.86
Oropouche virus efficiently replicates and is immunostimulatory in vivo in nonhuman primate species 1.00
Elucidating the mechanism by which HIV-1 nucleocapsid mutations confer resistance to integrase strand transfer inhibitors 0.80
The discovery of a Legionella phage explains a key determinant of human disease 0.22
Intravenous AAV9-ATP7A plus subcutaneous copper histidinate optimizes outcomes in a lethal Menkes disease mouse model 0.29
Striatal dopamine signals errors in prediction across different informational domains 0.93
10 2.23
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines 0.31
Adeno-associated virus gene therapy–mediated CCR5 blockade suppresses virus replication long term in SHIV-infected macaques 0.03
Immunopeptidomics can inform the design of mRNA vaccines for the delivery of Mycobacterium tuberculosis MHC class II antigens 0.05
Sex differences in HIV-1 reservoir cell selection are linked to altered innate immune profiles 0.09
Functional, immunogenetic, and structural convergence in influenza immunity between humans and macaques 0.63
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins 0.12
Nasal and systemic immune responses correlate with viral shedding after influenza challenge in people with complex preexisting immunity 0.45
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial 0.04
Protective envelope dimer epitope–like antibodies are elicited against dengue virus in children after infection and vaccination 0.40
Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates 0.11
2 0.17
Multitrait analysis of genome-wide association studies expands eosinophilic esophagitis genetic susceptibility and polygenic risk scores 0.06
Prediction and Characterization of Genetically-Regulated Expression of Asthma Tissues from African-Ancestry Populations 0.11
2 0.14
Prevention of urinary stones with hydration: a randomised clinical trial of an adherence intervention 0.08
Maternal and neonatal outcomes after infection with monkeypox virus clade I during pregnancy in DR Congo: a pooled, prospective cohort study 0.07
1 0.00
Absolute and relative risks of mental disorders in families: a Danish register-based study 0.00
4 0.37
Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges 0.17
Daily Mosnodenvir as Dengue Prophylaxis in a Controlled Human Infection Model 0.07
Safety and Immunogenicity of an rVSV Lassa Fever Vaccine Candidate 0.09
Belzutifan for Advanced Pheochromocytoma or Paraganglioma 0.04

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.